Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2000Leukemia & lymphoma/Leukemia and lymphoma

18-FDG-PET as a Prognostic Indicator in the Treatment of Aggressive Non-Hodgkin's Lymphoma-Comparison with CT

View Full Paper
Ask AI
Bookmark
Share

Authors

NMN. George MikhaeelGuy's and St Thomas' NHS Foundation TrustATA.R. TimothyLeeds General InfirmaryMOM. J. OʼDohertyOak Ridge National Laboratory

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mikhaeel et al. (2000) studied this question.

synapsesocial.com/papers/6a1094afd478ddac0ffd3705https://doi.org/10.3109/10428190009113384
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Post-Therapy CT-Detected Mass in Lymphoma Patients1982 · 60 citations
  2. 2Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma1993 · 2,166 citations
  3. 3Extranodal malignant lymphoma: detection with FDG PET versus CT.1998 · 323 citations